Safety of HIV medications – new podcast out now

In focus / 04 May 2022

Henry Zakumumpa from Makerere University School of Public Health airs his research on HIV care and treatment strategies in Uganda and the need for more robust pharmacovigilance.


With the right care, people infected with HIV can lead long and healthy lives. But as with any life-long medical treatment, it is important to acknowledge and manage any side effects.  

In the latest episode of Drug Safety Matters, Henry Zakumumpa from Makerere University School of Public Health tells podcast host Federica Santoro about the potential harms of new HIV therapies and the challenges faced by pharmacovigilance specialists in Uganda. 

Subscribe by visiting the Drug Safety Matters website or listen in right here:

You may also like


The One Health approach aims to uphold human, animal, and environmental health

The One Health approach emphasises how human, animal and environmental health are interlinked and must be prioritised to prevent future global health crises.

In focus / 20 February 2025

It takes a community to make medicines safer for all

The ‘PV in the Community’ special interest group explores how a community-focused approach can enhance medication safety and foster a more patient-centric pharmacovigilance system.

In focus / 10 March 2025

New film shines a light on Colombia’s pharmacovigilance journey

The latest "WHO PIDM in Focus" film highlights the collaboration between WHO, UMC, and Colombia in the development of medicines and vaccines safety in the country.

In focus / 27 February 2025